HBC Immunology

HBCI Focuses on Discovering and Developing Peptides that Normalize the Tumor Microenvironment to Enhance the Performance of Immunotherapy and Chemotherapy. Its First Targeted Indication is Advanced Prostate Cancer, with the Goal of Entering Earlier Stages of the Disease and Ultimately Improving Patients' Quality of Life and Survival Rates. Other Potential Cancer Indications Undergoing In Vitro Studies Include Breast Cancer and Ovarian Cancer.